We have studied the action of GH on the production of hormones, growth factors, growth factor-binding protein and the occurrence of apoptosis in bovine ovarian granulosa cells, as well as the role of cAMP-stimulated protein kinase A (PKA) in the mediation of these effects. For this purpose we investigated the effects of exogenous bovine GH (0·001-10 µg/ml), PKA blockers KT5720 (100 ng/ml) and adenosine-3 ,5 -monophosphothiodate (Rp-cAMPS) (1 µmol), alone and in combination, on IGF-I, IGF-binding protein (IGFBP)-3, oxytocin, progesterone and estradiol secretion, cAMP and PKA content and the occurrence of apoptosis.
Introduction
Growth hormone (GH) is an important regulator of ovarian functions. The presence of GH, related mRNA (women: Schwarzier et al. 1997) and GH receptors (rat: Lobie et al. 1990 , women: Tamura et al. 1994 , cow: Kirby et al. 1996 have been demonstrated in ovarian cells. GH treatment can increase the number of receptors to gonadotropin ( Jia et al. 1986 ) and epidermal growth factor (Hattori et al. 1994) in rat ovarian cells, and regulate the secretion of insulin-like growth factor I (IGF-I), IGF-binding protein (IGFBP)-3, steroid and nonapeptide hormones, plasminogen activator and prostaglandins by fish (Singh & Thomas 1993) , rodent ( Jia et al. 1986 , Apa et al. 1994 , 1996 , human (Sirotkin & Schaeffer 1995) , sheep (Wathes et al. 1995) , bovine (Sakal et al. 1992 , Sirotkin & Nitray 1994 , Spicer & Echternkamp 1995 , Makarevic & Sirotkin 1996 , Sirotkin 1996 and porcine (Spicer & Echternkamp 1995 , Samaras et al. 1996 , Sirotkin et al. 1998a ovarian cells. On the other hand, several authors have failed to find an influence of GH on IGF-I release by sheep ovaries (Wathes et al. 1995) and on IGF-I, IGFBP-2 and IGFBP-3 mRNA content in bovine ovaries (Kirby et al. 1996) . In addition, GH is able to control oocyte maturation (cow: Sirotkin 1996 , Izadyar et al. 1997a and ovulation (human: Blumenfeld & Amit 1996) . Furthermore, GH is a known suppressor of apoptosis in rodent ovaries . The effects of GH on apoptosis and IGFBP-3 release by bovine ovarian cells have not been previously studied.
The mechanisms of GH action on ovarian function are not completely understood. Part of the GH effect on ovarian secretory activity, apoptosis and oogenesis (sheep: Wathes et al. 1995 , rodents: Apa et al. 1994 , 1996 , cow: Kirby et al. 1996 , Izadyar et al. 1997b , human: Ovesen 1998 , pig: Sirotkin et al. 1998a ) are probably not mediated by IGF-I, but directly through ovarian GH receptors (see above). In non-ovarian tissues, GH receptors are associated with intracellular tyrosine or serine-threonine mitogenactivated protein (MAP), PI3, JAK2 kinases, protein kinase C, activators of transcription Stat, adapter protein Shc, insulin receptor substrates, and second messengers diaglycerol, calcium and nitric oxide (Rotwein et al. 1994 , Campbell 1997 , Carter-Su & Smith 1998 , Sekine et al. 1998 , Wakai et al. 1998 . There are indications that cAMP and cAMP-dependent protein kinase A (PKA) may also be involved in the mediation of GH action on some nonovarian cells: GH was able to stimulate cAMP production by adipocytes (Yip & Goodman 1999) , whilst regulators of PKA prevented the effect of GH on adipocytes (Eriksson & Tornqvist 1997 ) and pancreatic cells (Sekine et al. 1996 (Sekine et al. , 1998 . There is evidence that the cAMP/PKA system can mediate the effect of GH on the reproductive system. GH is able to increase cAMP release by bovine oviductal cells (Makarevich & Sirotkin 1997) , rat Leydig cells (Horikawa et al. 1989) , and seatrout (Singh & Thomas 1993) , rat (Hattori et al. 1994) , bovine (Sirotkin & Nitray 1994 , Makarevic & Sirotkin 1996 and human (Sirotkin & Schaeffer 1995) ovarian cells, although the observation on rat ovarian cells has not been confirmed by other authors (Apa et al. 1994 (Apa et al. , 1996 . Furthermore, the steroidogenic effect of GH on seatrout ovarian cells was mimicked by activators of cAMP and PKA (Singh & Thomas 1993) . GH action on the maturation of oocyte-cumulus complexes was prevented by an inhibitor of cAMP/PKA, but not by an inhibitor of JAK2 kinase (Izadyar et al. 1997a) . Taken together, these data indirectly suggest that GH may control reproductive functions through the cAMP/PKA system. Direct evidence for this hypothesis, however, has been not yet been obtained.
The aims of this study were to confirm the action of GH on IGF-I, oxytocin, progesterone and estradiol secretion, to examine the effect of GH on IGFBP-3 and the occurrence of apoptosis in cultured bovine ovarian granulosa cells, and to determine whether cAMP-stimulated PKA may be the mediator of these effects.
Materials and Methods
Preparation, culture and processing of granulosa cells Granulosa cells were collected from the ovaries of Holstein cows (2-4 years of age), during the early and middle follicular phase of the estrous cycle, after slaughter at a local abattoir. They were processed as described previously (Sirotkin 1996) . Briefly, the content of 2-5 mm diameter follicles was aspirated and a suspension of granulosa cells isolated by repeated (three times) centrifugation (200 g, 10 min) and pipetting in fresh incubation medium. The medium was DMEM/F-12 (1:1) mixture (Sigma, St Louis, MO, USA) supplemented with 10% bovine fetal serum (Institute of Veterinary Medicine, Brno, Czech Republic) and 1% antibiotic-antimycotic solution (Sigma). Granulosa cells (1 10 6 cells/ml) intended for RIA or Western immunoblotting were cultured in 2 ml culture medium in Falcon 24-well plates (Becton Dickinson, Lincoln Park, NJ, USA), whilst cells intended for immunocytochemical analysis were incubated in 300 µl medium in Lab-Tek chamber slides (Nunc A/S, Kamstrup, Roskilde, Denmark). All cells were precultured in medium at 37 C under 5% CO 2 in humidified air. After 2 days of preculture the medium was replaced with medium of the same composition. Control groups contained either no cells (blank control) or cells but no exogenous hormones or drugs. Experimental groups received 0·001, 0·01, 0·1, 1 or 10 µg/ml of immunological grade bovine GH (bGH; USDA-bGH-B-1) kindly provided by Dr J A Proudman (USDA Animal Hormone Program, Beltsville, MD, USA), PKA inhibitors (Calbiochem-Novabiochem Corporation, La Jolla, CA, USA), adenosine-3 ,5 -monophosphothiodate (RpcAMPS; 1 µmol), KT5720 (100 ng/ml) alone or in combination with bGH at the concentrations mentioned above. KT5720 was dissolved in 50 µl dimethyl sulfoxide (DMSO) to a final concentration of 1 mg/ml. Immediately before the experiment, these stock solutions were dissolved in incubation medium so that the content of DMSO did not exceed 0·001% of medium. Other substances were dissolved in medium immediately before the experiment. After 2 days of culture the medium from the plate wells was gently aspirated and frozen at 18 C to await RIA. Cultured cells were lysed in ice-cold kinase lysis buffer (1% Triton X-100, 0·5% Igepal NP-40, 5 mM EDTA, 20 µg/ml phenylmethylsulfonyl fluoride, 10 µg/ml aprotonin, 10 µg/ml leupeptin, 10 mM pepstatin sodium ortovanadate in phosphate-buffered saline (PBS), pH 7·5, all from Sigma, 50 µg/well) and frozen at 18 C to await gel electrophoresis and immunoblotting. Chamber slides were washed three times in PBS, fixed for 1 h at 5 C with a pure acetone (Lachema, Brno, Czech Republic), air dried and kept at +4 C to await immunocytochemical analysis. After culture, before lysis of cells, cell number and viability were determined by Trypan blue staining and hemocytometer. No statistically significant differences in these indices between control and experimental groups were observed.
Immunoassay
Concentrations of substances in 25-100 µl incubation medium were determined by RIA/immunoradiometric assay (IRMA). Progesterone, estradiol and IGFBP-3 were assayed using RIA/IRMA kits from DSL (Webster, TX, USA), whilst oxytocin was measured using an RIA kit from UVVVR (Prague, Czech Republic). Concentrations of IGF-I were determined by RIA according to Furlanetto et al. (1977) with our modification (Makarevich & Sirotkin 1997) . All RIA/IRMAs were validated for the culture medium used. The characteristics of these assays are presented in Table 1 .
Protein gel electrophoresis and immunoblotting
Frozen lysates of granulosa cells were mixed 1:1 with electrophoretic buffer (0·0625 M Tris-base, 2% SDS, 10% glycerol, 5% 2-mercaptoethanol, 0·003% bromophenol blue, all from Sigma), boiled at 95 C for 3 min and subjected to SDS-PAGE in 4% and 10% polyacrylamide in stacking and resolving gels respectively at 25 mA constant current according to Laemmli (1970) . Then the samples were transferred for 1 h to nitrocellulose membranes (ECL Hybond; Amersham International plc, Little Chalfont, Bucks, UK) using a semi-dry trans-blotter (Bio-Rad Labs, Richmond, CA, USA). Endogenous peroxidase in the samples was quenched by incubation in 3% H 2 O 2 for 15 min. Non-specific binding of antiserum was prevented by incubation in 5% blot-qualified bovine serum albumin (Amersham International plc) in TTBS (20 nM Tris-base, 137 nM NaCl, 0·1% Tween-20). Blocked membranes were probed with mouse monoclonal antibody against the catalytic (IgG 2b, clone 5; Transduction Laboratories, Lexington, KY, USA; dilution 1:250) or regulatory (IgG 2b, clone 18; Transduction Laboratories; dilution 1:1000) subunit of PKA. These antibodies cross-react with the related subunits of human, dog, rat, bovine and porcine PKAs. Membranes were then incubated with secondary horseradish peroxidase-conjugated anti-rabbit IgG antibody and visualized using ECL detection reagents and ECL Hyper-film (all from Amersham International plc). Incubation medium without cells, or fluid aspirated from bovine ovarian follicles 2-5 cm in diameter (separated from cells by centrifugation as described above) were used as negative controls. A rat pituitary cell lysate (Transduction Laboratories), dilution 1:250, containing significant amounts of both PKA subunits was used as a positive control. The molecular weights of fractions were evaluated using a molecular weight calibration kit (14·4 to 94·0 kDa; Serva, Heidelberg, Germany).
Immunocytochemical analysis
PKA subunits and cAMP were detected in granulosa cells plated in the chamber slides using immunocytochemistry (Osborn & Isenberg 1994) . Primary mouse monoclonal antibodies (Transduction Laboratories) against the regulatory subunit I (dilution 1:1000) and catalytic subunit C-(1:250) were used for the detection of PKA. The activities and specificities of these antibodies at these dilutions were confirmed prior to experiment by Western blotting (see above). For detection of intracellular cAMP, a primary rabbit polyclonal anti-cAMP antiserum (kindly provided by Mrs S Greenhut, National Hormone and Pituitary Program, NIH, Rockville, MD, USA; dilution 1:100) was used. This antiserum did not express species-specific differences in binding to bovine, porcine and rabbit ovarian cells and showed no binding to 5 -AMP, 5 -ADP, 5-ATP or 3 ,5 -cGMP. For visualization of the binding sites of primary antibodies, secondary polyclonal antibodies against mouse or rabbit IgGs, labeled with horseradish peroxidase (Sevac, Prague, Czech Republic; dilution 1:500) and 3-3 diaminobenzidine (DAB) reagent (Boehringer Mannheim GmbH, Mannheim, Germany; 10%) were used. Cells treated with secondary antibodies and DAB, omitting primary antibodies, were used as a negative control. The presence of PKA or cAMP immunoreactivity in the cells was determined by light microscopy.
TUNEL analysis
Visualization of apoptotic cells (containing fragmented DNA) in chamber slides was performed by the TUNEL (terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick end labeling) method (In Situ Cell Death Detection Kit and DAB reagent; Boehringer Mannheim). As a negative control, fixed and permeabilized cells incubated without TdT, but with secondary antibodies and DAB, were used. As a positive control, permeabilized cells were incubated with bovine pancreatic DNase I (Boehringer Mannheim, 0·01 mg/ml; 10 min at room temperature) before TdT treatment to induce DNA fragmentation. The presence of TUNEL immunoreactivity in each cell was determined by visual inspection of cultures using light microscopy.
Statistics
Each experimental group was represented by four culture wells or chambers. Assays of hormone and growth factor content in incubation medium were performed in duplicate. Proportions of cells containing specific immunoreactivity (PKA, cAMP or TUNEL) were calculated on the basis of inspection of a minimum of 1000 cells per chamber. The data shown are means of values obtained in four to six separate experiments performed on separate days using separate pools of granulosa cells, each obtained from 20-40 animals. In the majority of experiments, treatment with GH alone and in combination with one PKA blocker were tested. In RIA/IRMA, the values of blank control were subtracted from the value determined in cell-conditioned medium to exclude any non-specific background. The rates of substance secretion were calculated per 10 6 viable cells/day. Significant differences between the experiments were evaluated using two-way ANOVA. When effects of treatments were revealed, data from the experimental and control groups were compared by Duncan's multiple range test. The coefficients of variation within the replicates within each group did not exceed 19%. Significant differences in the proportion of cells containing PKA, cAMP or TdT immunoreactivity between the groups were evaluated by the Chi-square test. Differences from control where P<0·05 were considered as significant.
Results

Effect of GH and PKA blockers on cAMP/PKA system
Immunocytochemical analysis showed that some granulosa cells possessed immunoreactivity to the catalytic and regulatory subunits of PKA (Figs 1 and 2 ). Both immunoreactive subunits of PKA were identified mainly in the nucleus, but in some cells PKA immunoreactivity was seen also in cytoplasm. Western immunoblotting confirmed that the fractions of cell lysate containing these immunoreactivities had molecular weights equivalent to regulatory (48 kDa) and catalytic (40 kDa) subunits of PKA, whilst follicular fluid did not contain these immunoreactivities (Fig. 3) . Immunoreactivity to anti-cAMP antiserum was demonstrated in the majority of cultured bovine granulosa cells, mainly in the cytoplasm (Fig. 4) .
Addition of GH to the incubation medium at a concentration of 100 ng/ml induced a significant (P<0·05) increase in the proportion of cells with the immunoreactive catalytic subunit of PKA. The proportion of cells revealing the regulatory PKA subunit was reduced (P<0·05; Fig. 2a) .
The PKA blocker KT5720 significantly (P<0·05) reduced the proportion of granulosa cells containing both the catalytic and the regulatory subunits of PKA (Fig. 2b) . Furthermore, it significantly (P<0·05) decreased the percentage of cells containing cAMP immunoreactivity (Fig. 4) .
The antagonistic cAMP analogue Rp-cAMPS also decreased (P<0·05) the proportion of cells revealing the regulatory but not the catalytic subunit of PKA (Fig. 2b) . It also resulted in a significant (P<0·05) decrease in the proportion of cells containing cAMP immunoreactivity (Fig. 4) . 
Effect of GH and PKA blocker on IGF-I, IGFBP-3 and hormone secretion and on occurrence of apoptosis
The results of the RIA/IRMA of the incubation medium showed that bovine granulosa cells are able to synthesize and secrete significant amounts of IGF-I, IGFBP-3, oxytocin, progesterone and estradiol (Figs 5 and 6) . GH increased the secretion of IGF-I by bovine granulosa cells. It significantly (P<0·05) stimulated IGF-I accumulation in the culture medium at all concentrations (0·01-10 µg/ml medium), although the greatest effect was observed at 1 ng/ml. KT5720 alone did not affect basal IGF-I secretion. When given together with GH, KT5720 substantially reduced the stimulation of IGF-I secretion and raised the GH concentration required for maximal effect from 1 ng/ml to 10 ng/ml (Fig. 5a) .
GH stimulated (P<0·05) IGFBP-3 production when given at concentrations of 1 and 10 ng/ml (maximal response at 1 ng/ml). The stimulatory effect of higher concentrations (0·1-10 µg/ml) was insignificant. KT5720, when given alone, significantly (P<0·05) inhibited secretion of IGFBP-3. In the presence of KT5720, the stimulatory effect of GH at concentrations of 1-10 ng/ml was suppressed. In the presence of GH at higher concentrations KT5720 gradually lost its inhibitory influence (Fig. 5b) .
Some decrease (P<0·05) in progesterone secretion was observed after the addition of GH at concentrations of Figure 5 Effect of bGH (0, 1, 10, 100, 1000, 10000 ng/ml medium) (solid bars) and bGH (0, 1, 10, 100, 1000, 10000 ng/ml medium) in combination with PKA inhibitor KT5720 (100 ng/ml) (hatched bars) of (a) IGF-I, (b) IGFBP-3 and (c) progesterone secretion by bovine granulosa cells cultured for 2 days with and without these additions in a serum-supplemented medium. Values are means S.E.M. *P<0·05 compared with control (medium without GH).
1-100 ng/ml. Higher concentrations did not affect progesterone output. KT5720 did not affect progesterone accumulation when given alone but it was able to eliminate the inhibitory effect of GH secretion at all concentrations except 10 µg GH/ml (Fig. 5c) .
GH exterted a concentration-dependent stimulatory influence on oxytocin secretion at concentrations of 1 µg/ml and above (P<0·05). Rp-cAMPS when given alone decreased (P<0·05) the secretion of oxytocin and reduced the stimulatory action of GH by about 50% (Fig. 6a) .
GH stimulated estradiol secretion (P<0·05) at concentrations of 10 and 100 ng/ml, with maximal effect at 100 ng/ml. Lower (1 ng/ml) and higher (1 µg/ml) GH concentrations had no effect, whilst the highest concentration (10 µg/ml) was inhibitory (P<0·05). Rp-cAMPS alone had no effect on estradiol secretion but it completely eliminated the biphasic effect of GH on estradiol secretion, preventing both stimulatory (10-100 ng GH/ml) and inhibitory (10 µg GH/ml) actions (Fig. 6b) .
TUNEL analysis demonstrated that a significant proportion of these cells at the end of culture had visible signs of apoptosis (binding of TdT in the nuclei; Figs 7, 8 and 9). GH prevented apoptosis in cultured bovine granulosa cells at all concentrations tested (0·01-1 µg/ml; P<0·05) in a concentration-dependent manner; the maximally effective concentration was 1 µg/ml (Fig. 8) . Rp-cAMPS given alone had no effect on apoptosis but it did prevent the suppressive action of GH (100 ng/ml). Moreover, the combination of GH and Rp-cAMP increased the percentage of apoptotic cells over the control value (Fig. 9 ).
Discussion
Our observations confirm previous reports (Sakal et al. 1992 , Sirotkin & Nitray 1994 , Spicer & Echternkamp 1995 , Kirby et al. 1996 , Makarevic & Sirotkin 1996 , Sirotkin 1996 , Gutierrez et al. 1997 ) on production of IGF-I, IGFBP-3, oxytocin, progesterone, estradiol and Figure 6 Effect of bGH (0, 1, 10, 100, 1000, 10000 ng/ml medium) (solid bars) and bGH (0, 1, 10, 100, 1000, 10000 ng/ml medium) in combination with PKA inhibitor Rp-cAMPS (1 mol) (hatched bars) on (a) oxytocin and (b) estradiol secretion by bovine granulosa cells cultured for 2 days with and without these additions in a serum-supplemented medium. Values are means S.E.M. *P<0·05 compared with control (medium without GH). cAMP by cultured bovine granulosa cells. This is probably the first demonstration of apoptosis and PKA subunits in bovine ovarian cells. Apoptosis in cows, as in other species, may be associated with ovarian remodeling, follicle selection and atresia (Paton & Collins 1992 . The presence of both PKA subunits, together with production of cAMP, suggests involvement of the cAMP/ PKA axis in the control of ovarian function. These substances can mediate the action of gonadotropins (Leung & Steele 1992 , Paton & Collins 1992 and GH (see below). PKA is a putatative intracellular substance which under physiological conditions is apparently not secreted; cell-free follicular fluid did not contain material corresponding to the properties of the PKA subunits. The smaller stained fraction (24 kDa) appearing below those corresponding to the catalytic (40 kDa) and regulatory (48 kDa) subunits probably represents degraded fragments of PKA which have accumulated in follicular fluid.
Our results support previous evidence (Sirotkin & Nitray 1994 , Spicer & Echternkamp 1995 , Makarevic & Sirotkin 1996 , Sirotkin 1996 ) that secretion of IGF-I, oxytocin, steroids and cAMP by bovine ovarian cells is under direct stimulatory control by GH. These observations are the first to show that GH can regulate IGFBP-3, apoptosis and PKA in bovine ovaries. The dose-response curve of the GH effect on steroids and other substances in bovine granulosa cells in general resembles the effect of GH (Sirotkin & Nitray 1994 , Spicer & Echternkamp 1995 , Makarevic & Sirotkin 1996 , Sirotkin 1996 , gonadotropins, IGF-I and other ligands (Berndtson et al. 1995 , Roullier et al. 1996 , Gutierrez et al. 1997 studied previously, although some differences between experiments and even within one experiment due to differences in origin, state and culture medium of bovine granulosa cells were observed.
The differences in hormone dose-response curves observed in our experiments may indirectly indicate the existence of multiple GH receptors or multiple GH receptor second messenger system. The pattern of influence of GH on PKA (stimulation of catalytic and inhibition of regulatory subunit) suggest that GH activates the process since only the catalytic PKA subunit is biologically active (enters the nucleus and activates phosphorylation of the nuclear transcription factor, cAMP-response elementbinding protein). Free regulatory PKA subunit is quickly degraded (Sassone-Corsi 1998) . The effect of GH may be to stimulate the formation or inhibit the catabolism of the catalytic subunit. In addition, GH may increase the dissociation of the catalytic and regulatory subunits of PKA and thereby promote the degradation of the regulatory subunit.
The inter-relationships between these GH effects and their physiological importance require further study. The fact that GH is able to inhibit progesterone (marker of ovarian cell luteinization) and stimulate estradiol (indicative of a follicular phenotype, see Paton & Collins 1992) suggests that GH may suppress luteinization in culture. This phenomenon requires further study. Increased estradiol production accompanied by low incidence of apoptosis is a characteristic of viable, non-atretic cells 
Figure 9
Effect of bGH (100 ng/ml medium), PKA inhibitor Rp-cAMPS (1 mol) and bGH (100 ng/ml medium) in combination with Rp-cAMPS (1 mol) on expression of apoptosis in bovine granulosa cells cultured for 2 days with and without these additions in a serum-supplemented medium. Values are means S.E.M. *P<0·05 compared with control (medium without additions). (Paton & Collins 1992 . Thus, GH may be an inhibitor of atresia in ovarian follicles. It may be supposed that GH activates the IGF/IGFBP system by stimulation both of IGF-I itself and its carrier/protector IGFBP-3. GH may stimulate IGF-I via oxytocin, or vice versa, because in cultured ovarian cells IGF-I and oxytocin can be stimulated reciprocally (Wathes 1989 , 1998a . IGF-I and oxytocin may be mediators of the GH effect on various ovarian functions. IGF-I, like GH, is known to prevent ovarian apoptosis , stimulate oocyte maturation (Sirotkin et al. 1998b , Izadyar et al. 1997b ) and stimulate ovarian steroidogenesis (Spicer & Echternkamp 1995 , Gutierrez et al. 1997 , Sirotkin et al. 1998a , whilst oxytocin can also stimulate steroid, IGF-I and IGFBP-3 secretion by ovarian cells (Wathes 1989 , 1998a .
The cAMP/PKA system is an important regulator of ovarian hormone secretion, growth factor production, apoptosis and oogenesis (Wathes 1989 , Paton & Collins 1992 , Singh & Thomas 1993 , Makarevic & Sirotkin 1996 , Izadyar et al. 1997a . Furthermore, the cAMP/PKA system may be invovled in the mediation of GH action on non-reproductive (Sekine et al. 1996 , Eriksson & Tornquist 1997 , Yip & Goodman 1999 and reproductive (Horikawa et al. 1989 , Singh & Thomas 1993 , Hattori et al. 1994 , Sirotkin & Nitray 1994 , Sirotkin & Schaeffer 1995 , Makarevic & Sirotkin 1996 , 1997 , Izadyar et al. 1997a organs. Sites of action of GH in the cAMP/PKA system require further study. For example, in adipocytes, GH can suppress lipolysis via activation of PKA, but without stimulation of classical PKA activators, adenylate cyclase, cAMP or G-proteins (Yip & Goodman 1999) . On the contrary, in our present and previous experiments with ovarian cells, a large number of cellular responses to GH were associated with initial activation of both cAMP and PKA irrespective of the possible next steps in the signaling pathway (MAP and other kinases mentioned in the Introduction). The effect of GH on PKA observed in the present experiments, together with previous observations of stimulatory effects of GH on ovarian cAMP production (Singh & Thomas 1993 , Sirotkin & Nitray 1994 , Sirotkin & Schaeffer 1995 , Makarevic & Sirotkin 1996 suggest that GH may stimulate cAMP/PKA within ovarian cells and that cAMP may mediate the action of GH on PKA. This hypothesis is confirmed by the effects of the PKA inhibitors -RpcAMPS and KT5720. These substances decreased the proportion of cells revealing catalytic and regulatory (KT5720) or only regulatory (Rp-cAMPS) subunits of PKA, probably via suppression of cAMP accumulation. Both inhibitors prevented or suppressed the GH effect on all the cellular secretions studied in our experiments. Furthermore, PKA inhibitor prevented the effect of GH on apoptosis. Moreover, the combination of GH+ Rp-cAMP, in contrast to GH and Rp-cAMP given alone, even stimulated apoptosis. One of the possible explanations of the apoptosis-stimulating effect of GH+Rp-cAMP may be the cumulative effect of GH and PKA inhibitors which, when given together in large doses, are able to stimulate the release of IGFBP-3 (Fig. 1b) which binds IGF-I, a known preventor of apoptosis in ovarian cells . In our experiments, KT5720 was able to inhibit both basal and GH-induced IGFBP-3 output (Fig. 1b) . This may indicate that active PKA may not only mediate GH action on IGFBP-3, but also promote basal IGFBP-3 release. This does not exclude the possibility that this basal IGFBP-3 secretion can be supported via PKA by some unknown factor contained in a serum-supplemented medium. Our observations of the prevention of an effect of GH by PKA inhibitors are consistent with a previous reports that PKA stimulators mimic the GH effect on ovarian steroidogenesis (Singh & Thomas 1993) , and that PKA inhibitors prevent GH action on oocyte maturation (Izadyar et al. 1997a) . Two sets of events -stimulation of the cAMP/ PKA system by GH and cessation of GH action after PKA blockade -suggest that several of the effects of GH on bovine ovarian cells are mediated through activation of the cAMP/PKA system. Yip RG & Goodman HM 1999 Growth hormone and dexamethasone stimulate lipolysis and activate adenyl cyclase in rat adipocytes by selective shifting Gi alpha2 to lower density membrane fractions. Endocrinology 140 1219-1227.
